Saturday 17 October 2026 Export BCRX’s income statement to Excel — free account

BioCryst Pharmaceuticals, Inc.

BCRX Healthcare Drug Manufacturers Specialty & Generic

BioCryst Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $874.8 million, up 94.1% from fiscal 2024. In the quarter to June 2026, revenue grew 33.6%, EPS grew 1,450.0%, free cash flow grew 153.2% and total debt rose 15.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

7.79 0.23 −2.87%

Follow BCRX

Alert me

Market cap: $2.1B
P/E: 0.0×
Fwd P/E: −3.5×
Dividend yield: —
F-score: 7/9
Altman Z: 1.83
Beneish M: −2.27
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	87.84%	91.07%	(88.68%)	2.05%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	5	4	7	5
ROA Full definition →	(75.79%)	(96.92%)	52.53%	(1.87%)
ROIC Full definition →	(610.55%)	(356.26%)	245.61%	66.46%
Return on Tangible Assets Full definition →	(135.02%)	(244.12%)	121.56%	(5.05%)
Average Days of Receivables Full definition →	42.98	45.03	44.57	55.57
Free Cash Flow per Share Full definition →	1.47	1.28	1.65	0.23
Free Cash Flow Full definition →	373.93	310.92	345.45	47.86
Capital Expenditures Full definition →	(2.21)	(2.18)	(1.92)	(2.34)
Other line items
Cash ROIC Full definition →	50.66%	57.00%	54.26%	9.60%
Accounts Receivable Turnover Full definition →	9.32	8.74	9.41	7.32
Accounts Payable Turnover Full definition →	2.09	1.89	1.39	1.64
Inventory Turnover Full definition →	3.77	3.09	2.83	2.45
Average Days of Payables Full definition →	199.87	201.15	302.83	129.86
Days of Inventory on Hand Full definition →	105.63	109.86	103.29	122.05
Tax Rate Full definition →	0.01	0.01	(0.01)	0.33
Research and Development Expense of Revenue Full definition →	21.02%	21.36%	18.99%	29.13%
Selling, General and Administrative Expense of Revenue Full definition →	35.86%	40.73%	39.85%	55.58%
Share Based Compensation of Revenue Full definition →	7.77%	9.00%	9.72%	13.77%
Interest Coverage Full definition →	(4.16)	(5.08)	4.32	0.85
Operating CF/Net income Full definition →	(0.98)	(0.68)	1.32	(5.72)
Depreciation/Fixed assets Full definition →	(0.03)	(0.10)	(0.33)	(0.56)
Capex/Depreciation Full definition →	7.08	2.24	0.65	0.50
Revenue per Share Full definition →	3.70	3.66	4.17	2.85
Operating CF per Share Full definition →	1.48	1.29	1.66	0.24
Capex per Share Full definition →	(0.01)	(0.01)	(0.01)	(0.01)
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Fold the line items

Columns are period end dates

Stockrow Weekly